The paper aimed to study the effect of lysyl oxidase-like 2 (LOXL2) on hepatocellular carcinoma (HCC) and explore the biological mechanisms of tumorigenicity and progression in HCC. The authors used four HCC cell lines to identify LOXL2. A lentiviral vector containing LOXL2-siRNA was constructed to silence the LOXL2 gene in SMMC-7721 cell line, and mRNA of the target gene was detected by real-time polymerase chain reaction (RT-PCR). The effect of LOXL2 silencing on the growth of SMMC-7721 cells was explored with flow cytometry profiling and BrdU labeling. Downstream genes of LOXL2 were selected by microarray and verified by Western Blotting. In the results, LOXL2 expression was significantly up-regulated in four types of HCC cell lines, therefore, SMMC-7721 cell line was selected for further exploration. When SMMC-7721 cell line was infected with LOXL2-siRNA, the expression of LOXL2 mRNA decreased. The silencing of LOXL2 resulted in the cell cycle arrest at the G1-phase, the increased apoptosis and the decreased growth of SMMC-7721 cells on the indicated days by BrdU. Moreover, the MDM2, BIRC3, CDC42, FOS and TGFBR2 genes were selected and verified to be the downstream genes of LOXL2. In conclusion, LOXL2 contributes to the genesis and progression of HCC cells and works by regulating downstream genes of LOXL2 in certain pathways. Therefore, LOXL2 may play an important role in the progression and prognosis of HCC.
Introduction
 A better understanding of hepatocellular carcinoma (HCC)-the most common primary liver cancer, which ranks globally as the third or fourth leading cause of cancer-related death [1, 2] , is imperative for improving early diagnosis and subsequent patient treatment and prognosis. Approximately 700,000 new cases are diagnosed each year [3] . HCC frequently leads to poor survival for local invasion and metastasis. Thus, it is important to explore biological target genes for determining treatment. The authors have focused the work on the biological role of lysyl oxidase-like 2 (LOXL2) genes in cancer cells.
Several members of the lysyl oxidase (LOX) family have recently emerged as important regulators of tumor progression [4] . LOXL2 is a member of the LOX gene family, of which the prototypic LOX and LOX-like proteins was encoded from 1 to 4 (i.e., LOXL1, LOXL2, LOXL3 and LOXL4), and has identified in mammalian genomes [5] . The LOX family promotes invasion and metastatic niche formation in many tissues and organs, such as skin, heart, lung, kidney, stomach, colon, ovaries and so on [6, 7] . In recent LOXL2 studies, it was shown that high LOXL2 expression was associated with poor prognosis in the colon, esophageal and squamous cell cancers, and that LOXL2 was correlated closely with tumor invasion and metastasis [8] [9] [10] [11] [12] [13] [14] [15] . Whether the LOXL2 gene contributes to the tumorigenicity and progression of HCC has seldom been studied.
In this study, the authors aimed to evaluate the cell cycle and apoptosis in LOXL2-knockdown SMMC-7721 cell line and examine the effects of LOXL2 silencing on the growth of HCC cell lines. Furthermore, they selected downstream genes of LOXL2 by microarray, verified them by Western 
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Blotting and then elaborated the downstream genes involved in the biological activities of LOXL2 in the context of HCC. Finally, they achieved the purpose of analyzing a LOXL2 mechanism in the occurrence and development of HCC.
Materials and Methods
Cell Lines and Culture
Human HCC cell lines, i.e., SMMC-7721, HepG2, Hep3B and Huh-7, were obtained from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China. Four kinds of cell lines were cultured in Dulbecco's modified eagle medium (DMEM;
Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum and antibiotics (100 units/mL penicillin and 0.25 µg/mL streptomycin) (HyClone, Logan, UT, USA). Cells were grown at 37.8 °C in a humidified atmosphere of 5% CO 2 and 95% air.
Construction of a RNAi Gene with a Lentiviral Vector
Cells expressing scrambled by short-hairpin RNA (shRNA) 5'-TTCTCCGAACGTGTCACGT-3' in a lentiviral vector were used as control, cells transfected with 5'-ATTACTCCAACAACATCAT-3' (LOXL2-siRNA) were used to silence LOXL2, and a human LOXL2 dsDNA oligo was synthesized with targeted siRNA sequences by Genechem Co. Ltd. (Shanghai, China). A lentiviral vector-pGCSIL-GFP plasmid (synthesized by Genechem Co. Ltd., Shanghai) was digested and connected with the dsDNA oligo, and subsequently transformed into competent E. coli. Lentiviral vector production and infection were conducted as previously described in Ref. [16] . Stable cell lines expressing LOXL2 shRNAs were selected on Luria-Bertani agar medium after 16 h cultivation at 37 °C and identified by real-time polymerase chain reaction (RT-PCR). The positive clones of recombinant plasmids were sequenced and extracted.
RT-PCR
Total RNA was extracted from SMMC-7721 cells using Trizol reagent (Invitrogen, San Diego, CA, USA) according to the manufacturer's instructions. cDNA was obtained by reverse transcription according to the M-MLV operating instructions (Promega, Madison, Wisconsin, USA). Then, RT-PCR was used to detect the mRNA of target gene. The primer sequences: 5'-GTCTGCGGCATGTTTGG-3' and 5'-GCTCTGGCTTGTACGCTTT-3' was for LOX2, and 5'-TGACTTCAACAGCGACACCCA-3' and 5'-CACCCTGTTGCTGTAGCCAAA-3' was for glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The step of PCR was 15 s at 95 °C, followed by 45 cycles of 5 s at 95 °C and 30 s at 60 °C. Melting curve analysis was used to check amplification. Data were calculated using the comparative 2 -ΔΔCt method.
Flow Cytometry
Detection of the Cell Cycle
The SMMC-7721 cells infected with lentiviral vector were harvested, centrifuged at 1,200 rpm for 5 min, washed with cold phosphate-buffered saline (PBS) at 4 °C one time and then gathered. Then, the cells were fixed in 70% ethanol and stored at 4 °C for more than 1 h. The cells were centrifuged and washed again, staining solution was added and the cells were resuspended for cell cycle analysis by using flow cytometry (FACSCalibur Instrument, American BD Company). All experiments were carried out in triplicate.
Detection of Apoptosis
The SMMC-7721 cells infected with lentiviral vector were harvested, washed with D-Hanks, and centrifuged at 1,500 rpm for 5 min. The precipitated cells were washed with PBS one time, centrifuged again and collected after being washed with binding buffer. The cell suspension was gathered with a final density of 1  10 6 -1  10 7 cells/mL, 5 uL annexin V-APC was added for 10-15 min. Then the cells were transferred for flow cytometry analysis (FACSCalibur Instrument, American BD Company). The apoptosis kit used in the test was Ebioscience 88-8007. All experiments were carried out in triplicate.
BrdU Labeling
The A microplate reader was used to measure the absorbance at a wavelength of 450 nm. All experiments were carried in triplicate. Data were calculated, analyzed and showed in a figure.
Microarray
To select candidate genes for further Western 
Western Blotting
Total proteins were extracted using standard radio-immunoprecipitation assay (RIPA) lysis buffer. Protein concentration was determined with a bicinchoninic acid (BCA) protein assay (HyClone-Pierce), and 20 g of protein was loaded in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 10% gels. Polypeptides were transferred onto polyvinylidene fluoride (PVDF) membranes and blocked with 5% nonfat dry milk. Immunoblots were incubated with the indicated antibodies: rabbit anti-baculoviral IAP repeat-containing proteins (BIRC3) (ab32059, Abcam), 1:500; mouse anti-cell division cycle 42 (CDC42) (ab187643, Abcam), 1:2,000; rabbit anti-FOS (ab7963, Abcam), 1:200; rabbit anti-murine double minute 2 (MDM2) (ab32103, Abcam), 1:200; rabbit anti-transforming growth factor β receptor II (TGFBR2) (ab61213, Abcam), 1:200. Secondary antibodies were anti-rabbit (1:2,000; Santa Cruz) and anti-mouse (1:2,000; Santa Cruz). Bands were visualized using an ECL chemiluminescence kit (Amersham) and X-ray analysis.
Statistical Analysis
All data are expressed as the mean ± SD. The intergroup difference was compared using a paired student's t-test (two tailed). In all cases, values of P < 0.05 were considered statistically as significant. These analyses were carried out using the IBM SPSS version 19.0 software.
Results
LOXL2 Expressed in Different Human HCC Cell Lines
RT-PCR showed that LOXL2 mRNA was significantly up-regulated in four types of HCC cell lines, particularly in HepG2 and SMMC-7721 cells (Fig. 1). 
Expression of LOXL2 mRNA Decreased in SMMC-7721 Cell Line with LOXL2-siRNA
The RT-PCR results showed that the expression of LOXL2 mRNA was decreased in SMMC-7721 cell line (P = 7.28827E -08, P < 0.01), which was infected with LOXL2-siRNA (Fig. 2) . It is suggested that the lentiviral vector played an effective role in LOXL2 gene silencing.
LOXL2 Silencing Induced Cycle Arrest in HCC Cells
When compared with the control, LOXL2 silencing dramatically decreased the fraction of G1 phase (P = 0.000, P < 0.001), and increased the percentage of S-phase (P = 0.06, P < 0.001) in SMMC-7721 cells (Fig. 3) . It indicated that LOXL2 contributed to the cell phase transition of HCC cells.
LOXL2 Silencing Increased Apoptosis in HCC Cells
After LOXL2 being silenced, the percentage of apoptosis was increased in SMMS-7721 cells (P = 5.63882E -06, P < 0.01) (Fig. 4) compared with the controls. The result revealed that LOXL2 silencing increased apoptosis of HCC cells.
LOXL2 Silencing Inhibited HCC Cell Growth
BrdU labeling was used to detect the absorbance folds of infected SMMC-7721 cells due to thymine replacement competition in the sequence in S phase, and it was found that LOXL2 silencing decreased the growth of SMMC-7721 cells on the reference days (P = 0.015068162, 0.01 < P < 0.05) (Fig. 5) . The results indicated that LOXL2 played a significant role in suppressing the growth of HCC cells in vitro.
Downstream Genes of LOXL2 Selected by Microarray in HCC Cells
Based on the screening criteria of an absolute fold change value > 1.5 and P value < 0.05, a total of 1,529 differentially expressed genes (DEGs) were identified in the control and LOXL2 silenced cells, in which there were 637 up-regulated genes and 892 down-regulated genes. The expression of LOXL2 was down-regulated (P = 3.21E -06, P < 0.01) after silencing. Subsequently, the DEGs were subjected to pathway enrichment analysis according to the Kegg and BioCarta information and ranked by P value, and the top 10 are shown in Fig. 6 . At the same time, the DEGs were subjected to gene ontology analysis according to the differences in gene functions. Then, LOXL2 was added into the first pathway banding according to the significant probability value that was the lowest (P = 2.59E -09, P < 0.01), and a gene network diagram was constructed (Fig. 7) . In conclusion, it was speculated that the target gene LOXL2 worked in HCC by regulating the MDM2, BIRC3, CDC42, FOS and TGFBR2 genes.
MDM2, BIRC3, CDC42, FOS and TGFBR2 Verified by Western Blotting
As shown in Fig. 8, MDM2 , BIRC3, CDC42, FOS and TGFBR2 genes were identified by Western Blotting. Among them, the expressions of BIRC3, MDM2 and TGFBR2 were decreased. On the contrary, CDC42 expression was increased, and there was no change in FOS expression. Therefore, the results indicated that in the "Kegg pathways in cancer", LOXL2 silencing down-regulated the expression of BIRC3, MDM2 and TGFBR2, up-regulated the expression of CDC42, and had no obvious effect on FOS.
Discussion
The present studies showed that the expanded expression of LOXL2 can promote tumor invasion and metastasis [8] [9] [10] [11] [12] [13] [14] [15] . Nevertheless, the function of LOXL2 in HCC has not yet been elucidated. In the study, LOXL2 mRNA had high expression levels in four types of HCC cell lines, particularly in HepG2 and SMMC-7721 cells. Because the sources of HepG2 and SMMC-7721 cells are different, the authors choose SMMC-7721 cell line for further research.
Additionally, the expression of LOXL2 mRNA was decreased in SMMC-7721 cell line infected with siRNA lentiviral vector. In parallel, the results provide new evidence that silencing LOXL2 expression could increase the rate of cell apoptosis and decrease the growth of HCC cells in vitro. Moreover, in the cell cycle distribution of SMMC-7721, LOXL2 silencing dramatically decreased the fraction of G1 phase and increased that of S phase; it indicated that LOXL2 contributes to HCC cell cycle distribution. If we artificially interfere in cell cycle phase, HCC growth maybe blocked. In the future, it will be beneficial in the clinical treatment of HCC patients.
Although it is known that LOXL2 can promote tumorigenicity and progression in HCC, many problems about this process remain unsolved, such as those regarding the regulatory mechanism of this process. Here, it was shown that the target gene LOXL2 worked in HCC by regulating the MDM2, BIRC3, CDC42 and TGFBR2 genes through microarray analysis. According to the results, LOXL2 up-regulated BIRC3, MDM2 and TGFBR2 genes, and down-regulated CDC42 significantly.
CDC42, which is a small GTPase belonging to the Rho subfamily, plays multiple roles in cellular functions, including cell proliferation, migration and apoptosis, and it even promotes malignant transformation [17] [18] [19] [20] [21] [22] . It was originally identified in S. cerevisiae as a mediator of cell division [23, 24] . Since its original discovery, CDC42 has been found to influence a variety of signaling events and cellular processes [25, 26] . The up-regulation of CDC42 is involved in cell polarity and cell movement [26, 27] . Previous studies have also demonstrated that CDC42 played a crucial role in the transforming growth factor (TGF) pathway [28] . Additionally, as a member of the transforming growth factor β family, TGF-β works as a multi-functional cytokine and plays an important role in cell proliferation, apoptosis and differentiation [29] . TGF-β is an important gene that has been identified as a cancer susceptibility gene that exerts tumor-suppressive effects that cancer cells must elude for malignant evolution [29] [30] [31] [32] . TGFBR1 and TGFBR2-two transmembrane serine/threonine kinase receptors, are required for TGF-β signaling transduction. Herein, it was demonstrated that when HCC occurs, LOXL2 exerts its effect by down-regulating the CDC42 gene and up-regulating the TGFBR2 gene. This result hinted that the target gene may be useful in tumor therapy.
MDM2 is an intracellular molecule with multiple biological functions that negatively regulate the tumor suppressor p53 [33] . The expression of MDM2 is linked to gain-of-function mutations in many tumors [34] . In addition, the inhibition of MDM2 was shown to block tumor growth or induce cell apoptosis in a number of tumors [35] [36] [37] [38] [39] . In addition, DNA amplification of BIRC3 has been observed in mouse liver and human lung cancers, liver carcinoma, oral squamous cell carcinoma, medulloblastoma, glioblastoma and pancreatic cancer [40] . In this study, the expression levels of MDM2 and BIRC3 were significantly lower in HCC cells with LOXL2 silencing, which means that LOXL2 up-regulated MDM2 and BIRC3 in HCC. A larger prospective study is needed to determine the exact roles of CDC42, TGFBR2, MDM2 and BIRC3 genes and their complex linkage in HCC.
Conclusions
In summary, LOXL2 contributes to the genesis and progression of HCC cells and works by regulating downstream genes of LOXL2 in certain pathways. Therefore, LOXL2 may play an important role in the progression and prognosis of HCC. Furthermore, additional studies will be required to fully understand the molecular mechanisms involved.
